info@novystem.com
NovystemNovystemNovystemNovystem
  • About us
    • Board of Directors
    • Scientific Team
  • Our Science
    • Biotech
    • Medtech
    • Friedreich Ataxia
    • Bedsores​
  • Pipeline
    • Biotech
    • Medtech
    • Nutraceuticals​
  • Products
  • News
  • Carrers
  • Contacts

Medtech

    Home Medtech

    Sep4Angio Device for the treatment of deep lesions and Bedsores

    Sep4Angio is a medical device able to efficiently generate an AngioPRP prevalently enriched of platelets and specific peripheral blood cells populations

    AngioPRP is enriched of trophic factors and T cells with angiogenic and anti-inflammatory features (Tang)

    AngioPRP also contains endothelial progenitor cells (EPC) that synergizing with Tang T cells has been demonstrated to have a key role in tissue repair.

    AngioPRP/Sep4Angio shows an exceptional efficacy in would healing

    AngioPRP/Sep4Angio

    Hyalomatrix

    After 21 days, AngioPRP/Sep4Angio induces a complete wound healing, while Hylamatrix induces repairing only of 70% of the lesion.

    Copyright 2022 NovyStem - Privacy Policy - Cookie Policy - Powered by
    • About us
      • Board of Directors
      • Scientific Team
    • Our Science
      • Biotech
      • Medtech
      • Friedreich Ataxia
      • Bedsores​
    • Pipeline
      • Biotech
      • Medtech
      • Nutraceuticals​
    • Products
    • News
    • Carrers
    • Contacts
    Novystem